Differential responses to larger volume intra-aortic balloon counterpulsation: Hemodynamic and clinical outcomes

David A Baran1, Gautam K Visveswaran2, Ahmed Seliem2

  • 1Division of Advanced Heart Failure, Sentara Heart Hospital, Norfolk, Virginia.

Insights

Intra-aortic balloon pump catheter (IABC) use improves cardiac output in most patients but does not affect in-hospital survival. Further research into cardiogenic shock pathophysiology is needed.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Medical Devices

Background:

  • The clinical benefit of intra-aortic balloon pump catheter (IABC) use, despite its 50-year history, remains debated.
  • A retrospective review of 76 patients with right heart catheterization data was conducted to assess IABC response and outcomes.

Purpose of the Study:

  • To examine the hemodynamic and clinical correlates of intra-aortic balloon pump catheter (IABC) use.
  • To assess patient response and outcomes following IABC insertion.

Main Methods:

  • Retrospective chart review of 76 patients who received IABC with a 50cc balloon for at least 1 hour.
  • Recorded demographics, comorbidities, lab values, and hemodynamic parameters at baseline and 15 hours post-insertion.

Main Results:

  • 60 out of 76 patients demonstrated improved cardiac output with IABC (responders).
  • Responders showed significant increases in cardiac output (3.6 to 5.2 L/min) and cardiac index (1.8 to 2.6 L/min/m²).
  • A baseline cardiac power index of 0.3 or less best predicted IABC response; in-hospital survival was similar between responders and non-responders.

Conclusions:

  • Most patients experience improved cardiac output with IABC, but survival rates remain unchanged.
  • Further investigation into the pathophysiology of cardiogenic shock is warranted.
Abstract